flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Study: slowed progression of CKD, cut cardiovascular events, mortality risk SGLT2 Inhibitors in the Management

GLP-1RA have been linked to gastrointestinal issues such as intolerable nausea and vomiting, and in rare cases, pancreatitis [2, 10]

For oral semaglutide specifically approved for weight loss, the FDA cleared a 25 mg version in December 2025 under the brand name Wegovy (the pill)

This hormone helps control your blood sugar levels and appetite

This theory of liability places clinics and medspas within the scope of state consumer-protection law whenever their marketing claims diverge from the actual regulatory status of the products they administer

Knowing your genetic profile helps you and your PlexusDx provider decide whether continuous therapy, higher baseline doses, or additional lifestyle support is best for your long-term success